Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance with C3 Deposits Secondary to Chronic Lymphocytic Leukemia. acbr. 2025;9(5):360-363. Accessed September 17, 2026. https://fortunejournals.org/ojs/index.php/acbr/article/view/15131